Last reviewed · How we verify

NCT03815760

Can Blood Flow Restriction Therapy Improve Strength for Shoulder External Rotators Better Than Exercise Alone

Status unknown NA Last updated 24 January 2019
What this trial tests

NA trial testing Blood Flow Restriction in Muscular Weakness in 60 participants. Status unknown.

Timeline
18 January 2019
Primary endpoint
30 May 2019
30 May 2019

Quick facts

Lead sponsorGeorge Fox University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date18 January 2019
Primary completion30 May 2019
Estimated completion30 May 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

George Fox University

Who can join

Adults 18 to 45, any sex, with Muscular Weakness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the ability of blood flow restriction therapy to improve strength of shoulder muscles during the sidelying external rotation (ER) exercise versus a control group who only performs the sidelying ER exercise.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood Flow Restriction

Trials testing the same drug.

Other George Fox University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03815760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing